Ann M. Hanly, EVP & Chief Technology Officer at Vir Biotechnology, Inc. (VIR), sold 28,336 shares at $9.45 ($268K) on 2025-02-24, disclosed to the SEC on 2025-02-25.
Scheduled sale ($268k) by EVP & Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.45 | 14,168 | $134K | 50.0% |
| 2 | $9.45 | 14,168 | $134K | 50.0% |
| Total | $9.45 avg | 28,336 | $268K | 100% |
| Filing → |
| VIR | SELL | 2023-03-31 | $120K | — | Filing → |
| VIR | SELL | 2023-02-24 | $120K | — | Filing → |
| VIR | SELL | 2022-03-31 | $138K | — | Filing → |